mynth
10/2026

WITTINGTON INVESTMENTS / FAIRFAX FINANCIAL take majority stake in BOOTS

UNITED KINGDOM Health Providers / Outpatient Care / Pharmacy EV $1–10bn

Context

Wittington Investments and Fairfax Financial agreed to acquire Boots from Sycamore Partners and the Pessina family for a total purchase consideration of $1–10bn, including assumed debt, implying an EV/EBITDA multiple of 5x–12x. The transaction covers Boots' retail operations in the UK and Ireland, Boots Opticians, No7 Beauty Company, and its Thailand and franchised businesses. Sycamore Partners and Stefano Pessina's family were to retain the group's other interests, including Farmacias Benavides and Alliance Healthcare Deutschland. Boots reported revenue of $1–10bn and EBITDA of $450–900M for the financial year ended in August, corresponding to an EBITDA margin of [members only]. The business employed more than 50,000 colleagues and had been re-established as a standalone company by Sycamore Partners the previous year. Following completion, Wittington and Fairfax were each to hold a 50% stake, with Wittington responsible for operational control. Galen Weston, Wittington's chairman, was expected to become chairman of Boots, while Fairfax committed up to approximately $ 2.3 billion towards the purchase price. The transaction was expected to close in the first quarter of 2027, subject to customary closing conditions, including antitrust approvals and clearances. CIBC Capital Markets and Morgan Stanley Canada acted as lead financial advisers to Wittington, alongside RBC Capital Markets and Barclays. Skadden, Arps, Slate, Meagher & Flom and A&O Shearman provided legal advice, while CIBC and Morgan Stanley Senior Funding acted as lead arrangers and provided acquisition financing. UBS Investment Bank and Rothschild & Co. led the financial advisory team for The Boots Group, alongside J.P. Morgan, Citi, Deutsche Bank Securities and Goldman Sachs, with Davis Polk & Wardwell serving as legal adviser. A&O Shearman also advised Fairfax, with its team led by M&A partners Sean Skiffington in Toronto and Nick Withers in London.

-> Deep-dive in Healthcare & Pharma market trends

Target

Founded in the nineteenth century, Boots is a pharmacy-led health and beauty retailer operating in the United Kingdom and Ireland. The company runs retail stores across both countries, together with its Boots Opticians business and the No7 Beauty Company brand portfolio. Its Thailand operations and franchised businesses extend the banner beyond its home markets. The offer combines in-store pharmacy and health services with beauty and personal care ranges sold under proprietary brands, including No7. Customers are individual consumers and patients who turn to Boots for health and beauty needs. The company is headquartered in the United Kingdom, with retail and optician outlets located across the UK and Ireland and additional activity in Thailand through franchised arrangements.

Ent. Value

$1–10bn

Equity Value

[members only]

Multiples

EV / Revenue

below 1.5x

EV / EBITDA

5x–12x

EV / EBIT

[members only]

Historical Financials (USD)

Year
Rev
EBITDA
EBIT
2025
$1–10bn
$450–900M
[members only]
2024
$1–10bn
$450–900M
[members only]

Similar deals in Health Providers

Similar deals in Health Providers

List of similar M&A transactions (Date, Acquirer, Target, Country, Sub-sector)
DateAcquirerTargetCountrySector
09/2026BRIDGEPOINTALTANOGERMANYVet Clinics
06/2026STAR CAPITALGlenholme Specialist CareUNITED KINGDOMNursing Homes
05/2026JARDINE MATHESONI-MED RADIOLOGY NETWORKAUSTRALIARadiology
05/2026MEHILÄINEN GROUPALERISSWEDENClinics / Hospitals
05/2026Kinderhook IndustriesEnhabitUNITED STATESClinics / Hospitals
05/2026STONEPEAKESTIA HEALTHAUSTRALIANursing Homes
04/2026COLOSSEUM DENTAL GROUPMEDICALSANITALYDental Centers
02/2026MERIEUX EQUITY PARTNERSHEALTH IN CODE (HIC)SPAINLabs (Biology)
01/2026GTCRDENTALCORPCanadaDental Centers
01/2026POINT VISIONCLINIQUE DE LA VISION (REFRACT SAS)FRANCEOphthalmology

REFERENCES

Valuation range: EV $1–10bn

Revenue range: $1–10bn

EBITDA range: $450–900M

EV/Revenue range: below 1.5x

EV/EBITDA range: 5x - 12x

Note: This page provides detailed data on a private equity M&A transaction. Detailed and exact financial metrics for the acquisition of BOOTS by WITTINGTON INVESTMENTS / FAIRFAX FINANCIAL are reserved for mynth community members. Register for free to unlock full data.

Authors: This transaction was contributed by a verified mynth contributor and cross-checked against available transaction documents and official company communications.

Press release: view release

Target: boots

Acquirer: fairfax financial / wittington investments